S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)
S&P 500   5,137.08 (+0.80%)
DOW   39,087.38 (+0.23%)
QQQ   445.61 (+1.51%)
AAPL   179.66 (-0.60%)
MSFT   415.50 (+0.45%)
META   502.30 (+2.48%)
GOOGL   137.14 (-0.95%)
AMZN   178.22 (+0.83%)
TSLA   202.64 (+0.38%)
NVDA   822.79 (+4.00%)
NIO   5.77 (+0.35%)
AMD   202.64 (+5.25%)
BABA   74.63 (+0.81%)
T   17.00 (+0.41%)
F   12.45 (+0.08%)
MU   95.15 (+5.01%)
CGC   3.21 (-2.43%)
GE   158.67 (+1.13%)
DIS   111.93 (+0.31%)
AMC   4.36 (+0.93%)
PFE   26.58 (+0.08%)
PYPL   60.54 (+0.33%)
XOM   105.78 (+1.21%)

Centessa Pharmaceuticals (CNTA) Insider Trading & Ownership

$10.87
+0.36 (+3.43%)
(As of 03/1/2024 ET)

Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.54%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$365,158.06
Get CNTA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Centessa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CNTA Insider Buying and Selling by Quarter


Centessa Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2024Harris RotmanSVPSell4,267$8.10$34,562.70  
9/20/2023Harris RotmanSVPSell37,484$6.29$235,774.36  
6/1/2023Antoine YverEVPSell6,500$4.45$28,925.00  
5/24/2023Tia L BushInsiderSell8,000$4.48$35,840.00  
5/1/2023Antoine YverEVPSell6,800$4.42$30,056.00  
(Data available from 1/1/2013 forward)












CNTA Insider Trading Activity - Frequently Asked Questions

Who is on Centessa Pharmaceuticals's Insider Roster?

The list of insiders at Centessa Pharmaceuticals includes Aaron Kantoff, Antoine Yver, David J Grainger, David M Chao, Gregory M Weinhoff, Harris Rotman, Iqbal J Hussain, Medicxi Ventures Management (J, Rubertis Francesco De, Saurabh Saha, Thomas Templeman, and Tia L Bush. Learn more on insiders at CNTA.

What percentage of Centessa Pharmaceuticals stock is owned by insiders?

11.54% of Centessa Pharmaceuticals stock is owned by insiders. Learn more on CNTA's insider holdings.

Which Centessa Pharmaceuticals insiders have been buying company stock?

The following insider purchased CNTA shares in the last 24 months: Saurabh Saha ($46,300.00).

How much insider buying is happening at Centessa Pharmaceuticals?

Insiders have purchased a total of 10,000 CNTA shares in the last 24 months for a total of $46,300.00 bought.

Which Centessa Pharmaceuticals insiders have been selling company stock?

The following insiders have sold CNTA shares in the last 24 months: Antoine Yver ($558,344.03), David M Chao ($30,301.72), Gregory M Weinhoff ($35,638.95), Harris Rotman ($270,337.06), Iqbal J Hussain ($33,184.60), Thomas Templeman ($17,849.46), and Tia L Bush ($35,840.00).

How much insider selling is happening at Centessa Pharmaceuticals?

Insiders have sold a total of 202,273 Centessa Pharmaceuticals shares in the last 24 months for a total of $981,495.82 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:CNTA) was last updated on 3/1/2024 by MarketBeat.com Staff